thrive glp 1 reviews consumer reports What We Learned This Year About Midlife GLP-1 Use It's important to study the

MarketLens Is the GLP-1 Market Still a Blockbuster Opportunity for Investors Key Takeaways The GLP-1 analogue market is exploding, projected to reach $268.4 billion by 2030 with a 30.6% CAGR , driven by rising obesity and diabetes rates and expanded therapeutic indications

Published November 6, 2025

GLP-1 drugs linked to lower risk for dementia in older adults with diabetes: Study A new study found that adults over the age of 60 and on a GLP-1 medication reduced their likelihood of developing dementia by 23 to 44%, depending which medication they were on

How much weight can I lose with prescription medication

Studies suggest that 2540% of weight lost on GLP-1 therapies may come from lean tissue, including skeletal muscle and bone

The CGRD is the largest multi-institutional electronic medical record (EMR) database in Taiwan [21], including 2 medical centers and five general hospitals, and information on more than 11 million patients from 2001 to 2019